These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 19266541)

  • 1. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0.
    Bazzoli C; Retout S; Mentré F
    Comput Methods Programs Biomed; 2010 Apr; 98(1):55-65. PubMed ID: 19892427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.
    Retout S; Comets E; Samson A; Mentré F
    Stat Med; 2007 Dec; 26(28):5162-79. PubMed ID: 17486667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SAEM algorithm for group comparison tests in longitudinal data analysis based on non-linear mixed-effects model.
    Samson A; Lavielle M; Mentré F
    Stat Med; 2007 Nov; 26(27):4860-75. PubMed ID: 17562540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.
    Lavielle M; Mentré F
    J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):229-49. PubMed ID: 17211713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics.
    Retout S; Mentré F; Bruno R
    Stat Med; 2002 Sep; 21(18):2623-39. PubMed ID: 12228881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REML estimation of variance parameters in nonlinear mixed effects models using the SAEM algorithm.
    Meza C; Jaffrézic F; Foulley JL
    Biom J; 2007 Dec; 49(6):876-88. PubMed ID: 17638294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREME.
    Yates JW
    Comput Methods Programs Biomed; 2009 Oct; 96(1):49-62. PubMed ID: 19410328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.
    Chan PL; Jacqmin P; Lavielle M; McFadyen L; Weatherley B
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):41-61. PubMed ID: 21088872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PFIM 4.0, an extended R program for design evaluation and optimization in nonlinear mixed-effect models.
    Dumont C; Lestini G; Le Nagard H; Mentré F; Comets E; Nguyen TT;
    Comput Methods Programs Biomed; 2018 Mar; 156():217-229. PubMed ID: 29428073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of different population pharmacokinetic algorithms.
    Colucci P; Grenier J; Yue CS; Turgeon J; Ducharme MP
    Ther Drug Monit; 2011 Oct; 33(5):583-91. PubMed ID: 21912327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.
    Dumont C; Chenel M; Mentré F
    J Biopharm Stat; 2014; 24(3):471-92. PubMed ID: 24697342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction discrepancies for the evaluation of nonlinear mixed-effects models.
    Mentré F; Escolano S
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):345-67. PubMed ID: 16284919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.
    Comets E; Brendel K; Mentré F
    Comput Methods Programs Biomed; 2008 May; 90(2):154-66. PubMed ID: 18215437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2007; 17(3):381-92. PubMed ID: 17479388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics.
    Retout S; Mentré F
    J Biopharm Stat; 2003 May; 13(2):209-27. PubMed ID: 12729390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model-based analyses of bioequivalence crossover trials using the stochastic approximation expectation maximisation algorithm.
    Dubois A; Lavielle M; Gsteiger S; Pigeolet E; Mentré F
    Stat Med; 2011 Sep; 30(21):2582-600. PubMed ID: 21793036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the performance of first-order conditional estimation (FOCE) and different expectation-maximization (EM) methods in NONMEM: real data experience with complex nonlinear parent-metabolite pharmacokinetic model.
    Bach T; An G
    J Pharmacokinet Pharmacodyn; 2021 Aug; 48(4):581-595. PubMed ID: 33884580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.